阿尼西坦和脑复康治疗脑外伤后记忆减退  

THE EFFICACY OF ANIRACETAM AND PIRACETAM IN TREATMENT OF BRAIN INJURY INDUCED MEMORY DECREASING

作　　者：曾立民[1] 陶志宇[1] 李建华[1] 肖龙波 卜振富[1] 付秀金 

机构地区：[1]解放军89医院神经外科

出　　处：《中国新药杂志》1996年第5期352-354,共3页Chinese Journal of New Drugs

摘　　要：阿尼西坦、脑复康、淀粉随机对照治疗脑外伤后记忆减退患者９０例。每组各３０例，分别服阿尼西坦胶囊０．２ｇ／次，脑复康片０．８ｇ／次，淀粉０．２ｇ／次，均３次／ｄ；共４周。结果临床总有效率阿尼西坦组８６．７％，脑复康组６３．３％，二组有显著差异（Ｐ＜０．０５）；阿尼西坦组记忆商平均增值为１５±９（Ｐ＜０．０１），脑复康组平均增值１０±７（Ｐ＜０．０１），两组间经ｔ检验有显著差异（Ｐ＜０．０５），说明阿尼西坦组疗效优于脑复康组，不良反应轻微，可以选用。patients with brain injury induced memory decreasing are randomly divided to receive aniracetam capsule in a regimen of 200 mg tid for 4 weeks,piracetam tablet in a regimen of 800 mg tid for 4 weeks,and amylum in a regimen of 200 mg tid for 4 weeks.The total response rate is 86.7% for aniracetam group and 63.3% for piracetam group,there is significant difference between the two groups.The mean memory quotient increase is 15±9 for aniracetam group and 10±7 for piracetam group and there is significant difference between the two groups.Results obtained showed that the efficacy of aniracetam is better than that of pircetam in treatment of memory decreasing induced by brain injury.

关 键 词：阿尼西坦 脑复康 脑损伤 精神状态判断法 

分 类 号：R651.150.5[医药卫生—外科学]